[1] Wang W Z, Jiang B, Sun H X, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults[J]. Circulation, 2017, 135(8): 759-771. [2] Serra R, Barbetta A, Fugetto F, et al. Emergent treatment of carotid stenosis: an evidence-based systematic review[J]. Minerva Chir, 2018, 73(5): 505-511. [3] Hou Q T, Yu C, Li S Y, et al. Characteristics of lipid profiles and lipid control in patients with diabetes in a tertiary hospital in Southwest China: an observational study based on electronic medical records[J]. Lipids Health Dis, 2019, 18(1): 13. [4] 陈伟伟, 高润霖, 刘力生, 等. 《中国心血管病报告2016》概要[J]. 中国循环杂志, 2017, 32(6): 521-530. [5] 中华医学会. 各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. [6] Gilbert O, Croffoot J R, Taylor A J, et al. Serum lipid concentrations among persons with spinal cord injury - a systematic review and meta-analysis of the literature[J]. Atherosclerosis, 2014, 232(2): 305-312. [7] Aznaouridis K, Masoura C, Vlachopoulos C, et al. Statins in stroke[J]. Curr Med Chem, 2019, 26(33): 6174-6185. [8] 李运航. Non-HDLC与ApoB作为动脉粥样硬化性心血管疾病预防目标的研究进展[J]. 海南医学, 2021, 32(8): 1043-1047. [9] Yi L, Tang J, Shi C G, et al. Pentraxin 3, TNF-α, and LDL-C are associated with carotid artery stenosis in patients with ischemic stroke[J]. Front Neurol, 2020, 10:1365. [10] Cherepanov D, Bentley T G K, Hsiao W, et al. Real-world cardiovascular disease burden in patients with atherosclerotic cardiovascular disease: a comprehensive systematic literature review[J]. Curr Med Res Opin, 2018, 34(3): 459-473. [11] Raina R, Young C, Krishnappa V, et al. Role of lipoprotein apheresis in cardiovascular disease risk reduction[J]. Blood Purif, 2019, 47(4): 301-316. [12] Nesti L, Mengozzi A, Natali A, et al. Statins, LDL cholesterol control, cardiovascular disease prevention, and atherosclerosis progression: a clinical perspective[J]. Am J Cardiovasc Drugs, 2020, 20(5): 405-412. [13] Pahlavanzade B, Zayeri F, Baghfalaki T, et al. Association of lipid markers with coronary heart disease and stroke mortality: a 15-year follow-up study[J]. Iran J Basic Med Sci, 2019, 22(11): 1325-1330. [14] Yeh Y T, Yin W H, Tseng W K, et al. Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level?-Data from a multicenter registry cohort study in Taiwan[J]. PLoS One, 2017, 12(10): e0186861. [15] 梁有峰, 郭增, 程宝山, 等. 非高密度脂蛋白胆固醇与载脂蛋白A-I比值与冠状动脉慢血流相关性分析[J]. 中国心血管病研究, 2022, 20(2): 161-165. [16] Wu B, Yu Z W, Tong T, et al. Evaluation of small dense low-density lipoprotein concentration for predicting the risk of acute coronary syndrome in Chinese population[J]. J Clin Lab Anal, 2020, 34(3): e23085. [17] 李友凤, 王春慧, 孙文先, 等. 总胆固醇/高密度脂蛋白胆固醇比值对脑卒中复发的预测价值[J]. 中国实用神经疾病杂志, 2020, 23(9): 771-775. [18] Wu J W, Wang A X, Li X, et al. Non-high-density lipoprotein cholesterol levels on the risk of asymptomatic intracranial arterial stenosis: a result from the APAC study[J]. Sci Rep, 2016, 6: 37410. [19] Wu J W, Chen S Y, Liu L P, et al. Non-high-density lipoprotein cholesterol vs low-density lipoprotein cholesterol as a risk factor for ischemic stroke: a result from the Kailuan study[J]. Neurol Res, 2013, 35(5): 505-511. [20] 王玮婧, 金蔚涛, 任红卫, 等. 非高密度脂蛋白与颈动脉粥样硬化程度的相关性研究[J]. 中华老年心脑血管病杂志, 2017, 19(9): 945-947. [21] Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease[J]. JAMA, 2009, 302(18): 1993-2000. [22] Imamura T, Doi Y, Ninomiya T, et al. Non-high-density lipoprotein cholesterol and the development of coronary heart disease and stroke subtypes in a general Japanese population: the Hisayama Study[J]. Atherosclerosis, 2014, 233(2): 343-348. [23] Tanabe N, Iso H, Okada K, et al. Serum total and non-high-density lipoprotein cholesterol and the risk prediction of cardiovascular events - the JALS-ECC -[J]. Circ J, 2010, 74(7): 1346-1356. [24] 郑刚. 秋水仙碱在心血管病防治中的地位和临床意义[J]. 中华老年心脑血管病杂志, 2022, 24(2): 216-218. [25] 韩新生, 徐建可,李相磊,等.急性脑梗死患者Cathepsin S/Cystatin C水平与动脉斑块性质及狭窄程度的相关性分析[J].中风与神经疾病杂志,2018,35(5):434-438. [26] 韩新生, 裘丽红,杨成森,等.前循环缺血性卒中患者颈动脉颅内外段血管粥样硬化斑块特点分析[J].实用医学杂志,2014,(17):2776-2778. |